JENNIFER STONE: Open Payments
NPI 1922287374 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,398 in 105 payments from 18 companies in 2025. Trend: 2023 $2,239 · 2024 $2,222 · 2025 $2,398
Food & beverage: $2,299Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $574 |
| Novartis Pharmaceuticals Corporation | 13 | $265 |
| Janssen Biotech, Inc. | 6 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $208 |
| Regeneron Healthcare Solutions, Inc. | 9 | $186 |
| GENZYME CORPORATION | 3 | $156 |
| Galderma Laboratories, L.P. | 6 | $137 |
| UCB, Inc. | 5 | $118 |
| LEO Pharma Inc. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 6 | $93 |
Products named: RINVOQ, DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, COSENTYX, Bimzelx, ILUMYA.
Industry payments across MS — which companies pay providers there.
